Effect and safety of granulocyte transfusions in pediatric patients with febrile neutropenia or defective granulocyte functions

Journal of Pediatric Hematology/Oncology

Volumn 33, Issue 6, 2011, Pages

  Atay, Didem ^a   Ozturk, Gulyuz ^b   Akcay, Arzu ^c   Yanasik, Melek ^b   Anak, Sema ^b   Devecioglu, Omer ^b  

^a Okmeydani Education and Research Hospital   (Brazil)

^b ISTANBUL UNIVERSITY   (Turkey)

^c Bakirkoy Maternity and Childrens Education and Research Hospital   (Turkey)

Author keywords

granulocyte transfusion; pediatric hematology oncology patients; severe infection

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; BONE PAIN; CHILD; CHRONIC GRANULOMATOUS DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEFECTIVE GRANULOCYTE FUNCTION; DISEASE SEVERITY; FEBRILE NEUTROPENIA; FEMALE; GRANULOCYTE TRANSFUSION; HEMATOLOGIC DISEASE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; INFECTION; LANGERHANS CELL SARCOMA; LEUKAPHERESIS; LEUKOCYTE COUNT; MACROPHAGE ACTIVATION SYNDROME; MALE; MYALGIA; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SAFETY; SCHOOL CHILD; SURVIVAL RATE; TREATMENT RESPONSE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GRANULOCYTES; HEMATOLOGIC NEOPLASMS; HUMANS; INFANT; LEUKAPHERESIS; LEUKOCYTE TRANSFUSION; MALE; NEUTROPENIA; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 80051762871     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31821ffdf1     Document Type: Article

References (17)

1. Ofran Y, Avivi I, Oliven A, et al. Granulocyte transfusions for neutropenic patients with life-threatening infections: A single center experience in 47 patients, who received 348 granulocyte transfusions. Vox Sang. 2007;93:363-369. (Pubitemid 350135080)
2. Sachs UJ, Reiter A, Walter T, et al. Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections. Transfusion. 2006;46:1909-1914. (Pubitemid 44631597)
3. Illerhaus G, Wirth K, Dwenger A, et al. Treatment and prophylaxis of severe infections in neutropenic patients by granulocyte transfusions. Ann Hematol. 2002;81:273-281. (Pubitemid 36067619)
4. Grigull L, Pulver N, Goudeva L, et al. G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis. Support Care Cancer. 2006;14:910-916.
5. Engelfriet CO, Reesink HW. Granulocyte transfusions. Vox Sang. 2000;79:59-96.
6. Vamvakas EC, Pineda AA. Meta-analysis of clinical studies of granulocyte transfusions in the treatment of bacterial sepsis. J Clin Apher. 1996;11:1-9. (Pubitemid 26137441)
7. Seidel MG, Peters C, Wacker A, et al. Randomized phase III study of granulocyte transfusions in neutropenic patients. Bone Marrow Transplant. 2008;42:679-684.
8. Dale DC, Price TH. Granulocyte transfusions therapy: A new era?. Curr Opin Hematol. 2009;16:1-2.
9. Liles WC, Rodger E, Dale DC. Combined administration of G-CSF and dexamethasone for the mobilization of granulocytes in normal donors: Optimization of dosing. Transfusion. 2000;40:642-644. (Pubitemid 30413315)
10. Guidelines for the collection of blood and blood components and to the use of blood products. Released by the Scientific Committee of the German Medical Association Publishers, Kö ln 2000.
11. Price TH, Bowden RA, Boeckh M, et al. Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation. Blood. 2000;95:3302-3309. (Pubitemid 30428457)
12. Adkins D, Goodgold H, Hendershott L, et al. Indium-labeled white blood cells apheresed from donors receiving G-CSF localize to sites of inflammation when infused into allogeneic bone marrow transplant recipients. Bone Marrow Transplant. 1997;19:809-812. (Pubitemid 27207897)
13. Freireich EJ, Levin RH, Whang J, et al. The function and fate of transfused leukocytes from donors with chronic myelocytic leukemia in leukopenic recipients. Ann N Y Acad Sci. 1964;113: 1081-1089.
14. Ikinciogullari A, Dogu F, Solaz N, et al. Granulocyte transfusions in children with chronic granulomatous disease and invasive aspergillosis. Ther Apher Dial. 2005;9:137-141. (Pubitemid 40734775)
15. Bielorai B, Toren A, Wolach B, et al. Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation. BMT. 2000;26:1025-1028.
16. Hübel K, Carter RA, Liles WC, et al. Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: A comparative analysis of feasibility and outcome for community donors versus related donors. Transfusion. 2002;42:1414-1421.
17. Kerr JP, Liakopolou E, Brown J, et al. The use of stimulated granulocyte transfusions to prevent recurrence of past severe infections after allogenic stem cell transplantation. Br J Haematol. 2003;123:114-118. (Pubitemid 37222767)